SCHEMBL26923744

SCHEMBL26923744

Cc1ccc(-n2c3ccccc3c3c4c(c5ccccc5n4-c4ccccc4)c4c(c5ccccc5n4-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)c32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
RXFP1 Q9HBX9 2/20 0.46
CYP1A1 P04798 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP1B1 Q16678 1/20 0.43
ATM Q13315 2/20 0.41
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPSR1 Q6W5P4 3/20 0.41
RAB9A P51151 3/20 0.41
HTT P42858 2/20 0.41
NPC1 O15118 2/20 0.41
XBP1 P17861 1/20 0.41
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
AVPR1A P37288 1/20 0.40
LMNA P02545 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26923740 0.99 ALDH1A1 (0.44) ALDH1A1RXFP1CYP1A1CYP1A2CYP1B1
SCHEMBL20385225 0.93 L3MBTL1 (0.47) ALDH1A1ATMKDM4EL3MBTL1RAB9A
SCHEMBL20385282 0.93 L3MBTL1 (0.47) ALDH1A1ATMKDM4EL3MBTL1RAB9A
SCHEMBL26923808 0.93 MAPT (0.45) ALDH1A1RXFP1CYP1A1CYP1A2CYP1B1
SCHEMBL26923778 0.92 NPSR1 (0.49) ALDH1A1RXFP1CYP1A1CYP1A2CYP1B1
SCHEMBL23311184 0.92 L3MBTL1 (0.51) ALDH1A1RXFP1ATMKDM4EL3MBTL1
SCHEMBL20385320 0.92 L3MBTL1 (0.46) ALDH1A1ATMKDM4EL3MBTL1RAB9A
SCHEMBL20385284 0.92 L3MBTL1 (0.44) ALDH1A1ATMKDM4EL3MBTL1HTT
SCHEMBL30168531 0.92 L3MBTL1 (0.44) ALDH1A1ATMKDM4EL3MBTL1HTT
SCHEMBL26923806 0.90 RXFP1 (0.46) ALDH1A1RXFP1L3MBTL1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device PIEZO1, LEF1, ODC1 ALDH1A1 21/4885RXFP1 3851/4885CYP1A1 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.